April, 1, 2019
KGK Science Joins the Natural Products Association as a New Board Member
“The Time is Right for Us to Be a Leader at the Table in Those Board Discussions”
London, ON – As part of the growth and outreach in the natural product space on a wide range of issues, including their lead on cannabidiol, KGK Science announced today that it has joined the Board of the Natural Products Association (NPA). Najla Guthrie, KGK Sciences' President and CEO, will serve as a Director.
KGK Science has served many of North America’s leading nutraceutical, natural health product and finished packaged goods companies such as Kraft Foods, Sanofi, Nature’s Bounty, and NuSkin. KGK works with clients to substantiate claims for products by conducting randomized clinical trials while also providing other research services, including study recruitment, regulatory compliance support, research consulting, safety dossiers to North American agencies (including studies for new dietary ingredients submitted to the Food and Drug Administration), and clinical trial design. In addition to their footprint in the health and wellness space for nutraceuticals and personal care products, KGK Science has recently expanded their reach to include cannabinoid and product research.
“KGK Science has been an NPA member for six years, but the time is right for us to be a leader at the table in those board discussions to drive a regulatory pathway for cannabidiol (CBD) and other nutraceuticals forward,” said Najla Guthrie, President and CEO of KGK Science. “KGK Science will be the first Contract Research Organization on the NPA Board, but we are more than a CRO. KGK Science is the leader in designing testing protocols and providing regulatory solutions to facilitate the explosion of science behind CBDs and their safety in North America. Consumers want to know more about the science behind claims made on products. We provide a valuable service for the natural products industry and increase consumer confidence behind those claims. KGK Science is in the business of providing substantiation for the claims made on CBDs, nutraceuticals, and other dietary ingredients in consumer products and confidence that they are safe for consumers,” added Ms. Guthrie.
KGK Science joins the Board of the venerable NPA, an advocacy, science, and regulatory organization and the leading trade association for the dietary supplement and natural products industry in the U.S. Founded in 1936, NPA represents over 1,000 members accounting for more than 10,000 retail, manufacturing, wholesale, and distribution locations of natural products, including foods, dietary supplements, and health/beauty aids. NPA unites a diverse membership, from the smallest health food store to the largest dietary supplement manufacturer. NPA serves as the industry watchdog on federal, state and local governments.
About KGK Science Inc.
KGK Science is a global contract research organization (CRO) that has specialized in human clinical trials for the health, nutrition and cannabis industry for over 22 years. KGK Science integrates scientific, clinical research, commercial and regulatory expertise to deliver solutions for propelling health and wellness products to market. KGK Science is focused on utilizing evidence based scientific research to best serve working partnerships with global brands marketing dietary supplements, branded ingredients, functional foods & beverages and medical foods. Seeking to maintain long-term relationships with our employees, customers, suppliers and other industry participants, KGK Science conducts its business on the basis of quality, reliability, innovation and integrity.
Contact: [Bibiane Zakaria]
519-438-9374 x 222
KGK Science Inc. Announces Appointment of Stephen Holmes to CFO/COO and Ashley ten Haaf to...
London, Ontario, September 10, 2018 – Najla Guthrie, President & CEO, of KGK Science Inc. (
KGK Science Inc. Announces Appointment of Mal Evans Ph.D to Chief Scientific Officer
London, Ontario, August 20, 2018 – Najla Guthrie, President & CEO, of KGK Science Inc. (
ChromaDex Clinical Trial Studying NIAGENÂ® Well Underway, With Eight Additional Collaborative Human
IRVINE, Calif., July 20, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food ...
KGK Synergize Inc. To Run Half Marathon In Support Of Vitamin Angels
LONDON, ON, NOVEMBER 14, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, will be participating in the Rock ‘n’ Roll Las Vegas...
Next Pharmaceuticals Acquires Sytrinol
SALINAS, Calif., June 4, 2013—Next Pharmaceuticals acquired the distribution rights, patents, trademarks and scientific knowledge for Sytrinol from KGK Synergize....
KGK Synergize Inc. Welcomes Angela Kelly To Our Team!
LONDON, ON, FEBRUARY 1, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, is very pleased to welcome Angela Kelly to the KGK Synergize Inc....
KGK Synergize Inc. Announces Settlement Of Its Lawsuit With Sourceone Global Partners, Inc.
LONDON, ON, January 27, 2012– KGK Synergize Inc. (“KGK”), a product development and contract research organization for the health nutrition industry, announced today the settlement of the lawsuit agains...
Dr. Mal Evans Has Been Selected As The Recipient Of The 2010-2011 Wil Award
LONDON, ON, JUNE 28, 2011 –Recently, Dr. Mal Evans has been selected as the recipient of the 2010-2011 WIL Award which recognizes individuals and /or organizations that have demonstrated the following qualities Win...
New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid
Read the article New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid using the link below: https://www.suna.org/download/members/unjarticles/2009/09apr/95.pdf...